Recs

11

2 Stocks Hitting Low Notes

By Motley Fool Staff | More Articles
February 19, 2009 | Comments (0)

When a stock hits a fresh low, it can either signal a dirt cheap dream stock or a dreadful stock to avoid. Separating the wheat from the chaff is difficult, but finding well-run companies at bargain-basement prices is a great way to accumulate a fortune over the long run.

With that in mind, we'll use the aggregate intelligence of the 125,000-plus investors participating in Motley Fool CAPS to see what the community is saying about stocks hitting 52-week lows today. The community's approval (signified by four- and five-star ratings) could indicate that further research is in order.

Here are two such stocks:

Company	Today’s Intraday Price	Industry	CAPS Rating (out of 5)	Fools Saying Outperform
BioMarin Pharmaceutical, Inc. (Nasdaq: BMRN )	$12.31	Biotechnology		868 of 911
National Instruments Corp (Nasdaq: NATI )	$18.48	Electronic Equipment, Instruments and Components		315 of 331

Source: Motley Fool CAPS, as of Feb. 19, 2009.

Top-rated biotechnology companies:

Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA ) : Stock price is 41% higher than last year.
Cephalon, Inc. (Nasdaq: CEPH ) : Stock price is 22% higher than last year.

Top-rated chemicals companies:

Sociedad Quimica y Minera (ADR) (NYSE: SQM ) : Stock price is 75% higher than last year.
Balchem Corp (Nasdaq: BCPC ) : Stock price is 1% higher than last year.

Join us on CAPS to learn more about these and countless other interesting stock ideas.

Best Odds in the Universe!
If you're interested in a 98.79% chance at beating the market... and a 70.84% chance at DOUBLING the market's return – Motley Fool Supernova could be just what you're looking for. And get this: We arrived at these odds from 10,000 random back-tested portfolios composed of Motley Fool Co-founder David Gardner's personal stock picks.

It's why David recently handpicked a small team of world-class portfolio managers. You see, he thinks these odds can get even better! And he'd like to prove it to you...

Simply enter your email address. And the answer to the question everybody is asking will be delivered to your inbox!

Disclosure is important to us here at The Motley Fool. The stocks mentioned in this article received their CAPS ratings from participants in The Motley Fool's CAPS service and have hit 52-week lows during today's trading. No individual person selected the stocks in this article, so there is no author to disclose an interest in them. Annual performance is measured over a 365-day period. Since this article was automatically generated by identifying the stocks rated by the CAPS community and by buyers in today’s market, it is possible that Motley Fool personnel (and even The Motley Fool itself, through our Million Dollar Portfolio, Motley Fool Pro, and Ready Made Millionaire services), have positions in these stocks. We thought you'd like to know that. You can learn more about The Motley Fool’s disclosure policy here.

Read/Post Comments (0) | Recommend This Article (11)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 835178, ~/Articles/ArticleHandler.aspx, 2/14/2012 11:49:09 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
	DOW	12,854.93	-19.11	-0.15%
	S&P 500	1,347.95	-3.82	-0.28%
	NASD	2,918.63	-12.76	-0.44%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Most Popular Articles

in the last seven days

Related Tickers

2/14/2012 11:21 AM

MNTA	$15.31		-0.14	-0.91%
Momenta Pharmaceut…		CAPS Rating:

NATI	$26.73		-0.23	-0.85%
National Instrumen…		CAPS Rating:

SQM	$58.42		-0.88	-1.48%
Sociedad Quimica y…		CAPS Rating:

BCPC	$34.94		+0.24	+0.69%
Balchem Corp		CAPS Rating:

BMRN	$37.76		-0.27	-0.71%
BioMarin Pharmaceu…		CAPS Rating:

CEPH	$0.00		+0.00	+0.00%
Cephalon, Inc.		CAPS Rating: